143 related articles for article (PubMed ID: 21500976)
1. Decoy-DNA against special AT-rich sequence binding protein 1 inhibits the growth and invasive ability of human breast cancer.
Yamayoshi A; Yasuhara M; Galande S; Kobori A; Murakami A
Oligonucleotides; 2011; 21(2):115-21. PubMed ID: 21500976
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-409 regulates the proliferation and invasion of breast cancer cell lines by targeting special AT-rich sequence-binding protein 1 (SATB1).
Chen Z; Sang MX; Geng CZ; Jia HQ
Bioengineered; 2022 May; 13(5):13045-13054. PubMed ID: 35611599
[TBL] [Abstract][Full Text] [Related]
3. Is SATB1 a master regulator in breast cancer growth and metastasis?
Zheng J
Womens Health (Lond); 2008 Jul; 4(4):329-32. PubMed ID: 19072498
[TBL] [Abstract][Full Text] [Related]
4. Plakoglobin represses SATB1 expression and decreases in vitro proliferation, migration and invasion.
Aktary Z; Pasdar M
PLoS One; 2013; 8(11):e78388. PubMed ID: 24260116
[TBL] [Abstract][Full Text] [Related]
5. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
[TBL] [Abstract][Full Text] [Related]
6. Fluvastatin-mediated down-regulation of SATB1 affects aggressive phenotypes of human non-small-cell lung cancer cell line H292.
Xu HY; Xue JX; Gao H; Na FF; Li H; Zhang T; Lu Y
Life Sci; 2019 Apr; 222():212-220. PubMed ID: 30557545
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation of long noncoding RNA UCA1 by SATB1 in breast cancer.
Lee JJ; Kim M; Kim HP
BMB Rep; 2016 Oct; 49(10):578-583. PubMed ID: 27697109
[TBL] [Abstract][Full Text] [Related]
8. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis.
Han HJ; Russo J; Kohwi Y; Kohwi-Shigematsu T
Nature; 2008 Mar; 452(7184):187-93. PubMed ID: 18337816
[TBL] [Abstract][Full Text] [Related]
9. SATB1 Knockdown Inhibits Proliferation and Invasion and Decreases Chemoradiation Resistance in Nasopharyngeal Carcinoma Cells by Reversing EMT and Suppressing MMP-9.
Zhou D; Ye C; Pan Z; Deng Y
Int J Med Sci; 2021; 18(1):42-52. PubMed ID: 33390772
[No Abstract] [Full Text] [Related]
10. SATB1 as oncogenic driver and potential therapeutic target in head & neck squamous cell carcinoma (HNSCC).
Panchal O; Wichmann G; Grenman R; Eckhardt L; Kunz-Schughart LA; Franke H; Dietz A; Aigner A
Sci Rep; 2020 May; 10(1):8615. PubMed ID: 32451408
[TBL] [Abstract][Full Text] [Related]
11. Expression and significance of SATB1 in the development of breast cancer.
Zhang S; Gao X; Ma Y; Jiang J; Dai Z; Yin X; Min W; Hui W; Wang B
Genet Mol Res; 2015 Apr; 14(2):3309-17. PubMed ID: 25966097
[TBL] [Abstract][Full Text] [Related]
12. SATB1 is Correlated with Progression and Metastasis of Breast Cancers: A Meta-Analysis.
Pan Z; Jing W; He K; Zhang L; Long X
Cell Physiol Biochem; 2016; 38(5):1975-83. PubMed ID: 27161300
[TBL] [Abstract][Full Text] [Related]
13. Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer.
Selinger CI; Cooper WA; Al-Sohaily S; Mladenova DN; Pangon L; Kennedy CW; McCaughan BC; Stirzaker C; Kohonen-Corish MR
J Thorac Oncol; 2011 Jul; 6(7):1179-89. PubMed ID: 21597389
[TBL] [Abstract][Full Text] [Related]
14. Silencing SATB1 inhibits proliferation of human osteosarcoma U2OS cells.
Zhang H; Qu S; Li S; Wang Y; Li Y; Wang Y; Wang Z; Li R
Mol Cell Biochem; 2013 Jun; 378(1-2):39-45. PubMed ID: 23516037
[TBL] [Abstract][Full Text] [Related]
15. ATM suppresses SATB1-induced malignant progression in breast epithelial cells.
Ordinario E; Han HJ; Furuta S; Heiser LM; Jakkula LR; Rodier F; Spellman PT; Campisi J; Gray JW; Bissell MJ; Kohwi Y; Kohwi-Shigematsu T
PLoS One; 2012; 7(12):e51786. PubMed ID: 23251624
[TBL] [Abstract][Full Text] [Related]
16. The genomic sequences bound to special AT-rich sequence-binding protein 1 (SATB1) in vivo in Jurkat T cells are tightly associated with the nuclear matrix at the bases of the chromatin loops.
de Belle I; Cai S; Kohwi-Shigematsu T
J Cell Biol; 1998 Apr; 141(2):335-48. PubMed ID: 9548713
[TBL] [Abstract][Full Text] [Related]
17. SATB1 plays an oncogenic role in esophageal cancer by up-regulation of FN1 and PDGFRB.
Song G; Liu K; Yang X; Mu B; Yang J; He L; Hu X; Li Q; Zhao Y; Cai X; Feng G
Oncotarget; 2017 Mar; 8(11):17771-17784. PubMed ID: 28147311
[TBL] [Abstract][Full Text] [Related]
18. Expression of SATB1 protein in the ductal breast carcinoma tissue microarrays - preliminary study.
Kobierzycki C; Wojnar A; Dziegiel P
Folia Histochem Cytobiol; 2013; 51(4):333-8. PubMed ID: 24497139
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of SATB1 increases the invasiveness of Jurkat cell via activation of the WNT/β-catenin signaling pathway in vitro.
Luo XD; Yang SJ; Wang JN; Tan L; Liu D; Wang YY; Zheng RH; Wu XH; Xu LH; Tan H
Tumour Biol; 2016 Jun; 37(6):7413-9. PubMed ID: 26678884
[TBL] [Abstract][Full Text] [Related]
20. EGFR aptamer-conjugated liposome-polycation-DNA complex for targeted delivery of SATB1 small interfering RNA to choriocarcinoma cells.
Dong J; Cao Y; Shen H; Ma Q; Mao S; Li S; Sun J
Biomed Pharmacother; 2018 Nov; 107():849-859. PubMed ID: 30142547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
